Search results for "From ACP Journal Club"

Results 31 - 40 of about 49 for "From ACP Journal Club".
Sort by: Relevance | Newest | Oldest

In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months

While fecal microbiota transplantation was effective in patients with moderate to severe irritable bowel syndrome in a randomized trial, long-term risks of the therapy remain uncertain, an ACP Journal Club commentary noted.
22 May 2020

In reflux-related heartburn unresponsive to PPIs, surgery increased treatment success vs active medical treatment

An ACP Journal Club commentary noted that physicians should not change their practice based on the results of the trial, which are in contrast to the literature and expert opinion, until they are confirmed by studies assessing objective primary end points.
27 Mar 2020

H. pylori eradication therapy may reduce gastric cancer risk; rifabutin-based therapy effective in industry-sponsored trial

A meta-analysis suggested that, in addition to preventing progression, early Helicobacter pylori eradication therapy reduces gastric cancer risk, and a novel rifabutin-based therapy may offer physicians another option for initiating eradication treatment, an ACP Journal Club commentary on both studies said.
25 Sep 2020

H. pylori treatment reduced risk for gastric cancer in patients with a family history of gastric cancer

While results of the trial support a test-and-treat screening approach for Helicobacter pylori in patients with a first-degree relative with gastric cancer, more research is needed before considering universal screening in this population, an ACP Journal Club commentary noted.
26 Jun 2020

After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality

The findings help clarify the ideal process for surveillance of clinical recurrence of colorectal cancer, an ACP Journal Club commentary said.
26 Oct 2018

Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease

Given the limitations of this large industry-funded trial, the only definitive conclusion one can draw is that patients on aspirin and rivaroxaban with low risk for bleeding may get a very small benefit from long-term proton-pump inhibitor therapy, an ACP Journal Club commentary said.
25 Oct 2019

In US veterans, PPIs were linked to increased all-cause and some cause-specific mortality compared with H2-blockers

The observational study cannot establish causation, and the only way to prove that proton-pump inhibitors (PPIs) cause the various adverse outcomes attributed to them is to compare them with placebo or no treatment in a randomized trial, according to an ACP Journal Club commentary.
27 Sep 2019

In compensated cirrhosis with portal hypertension, beta-blockers reduced a composite of decompensation or death

The trial results cannot be generalized to all patients with cirrhosis, and future trials should look at whether similar effects could be achieved simply by limiting salt intake, an ACP Journal Club commentary said.
23 Aug 2019

In uncomplicated acute appendicitis, 61% of patients initially treated with antibiotics had not had appendectomy at 5 years

While delay of surgery was not associated with major complications, potential candidates for nonsurgical management of uncomplicated acute appendicitis should be chosen carefully, an ACP Journal Club commentary said.
25 Jan 2019

In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response

Bezafibrate is currently unavailable in the U.S., but fenofibrate can be offered off-label in these patients with close monitoring of adverse effects, an ACP Journal Club commentary said.
26 Oct 2018

Result Page: Prev   1   2   3   4   5   Next